Gates Frontier/William H. Gates III Own 2,365,664 EVLVW Shares (1.4%)
Gates Frontier, LLC and William H. Gates III reported beneficial ownership of 2,365,664 shares of Evolv Technologies Holdings, Inc. Class A common stock, representing 1.4% of the outstanding shares.
Rhea-AI Filing Summary
Gates Frontier, LLC and William H. Gates III reported beneficial ownership of 2,365,664 shares of Evolv Technologies Holdings, Inc. Class A common stock, representing 1.4% of the outstanding shares. The percent is calculated using 171,891,467 shares outstanding as of August 11, 2025, per the issuer's report. Gates Frontier is organized in Washington and WHG is a U.S. citizen. The filing states the shares were not acquired to influence control of the issuer and includes execution by an authorized attorney-in-fact dated September 22, 2025.
Positive
- Clear disclosure of beneficial ownership including exact share count and percentage
- Certification that the shares are not held to change or influence control, aligning with Rule 13G reporting
- Signature and authorization documented via attorney-in-fact, supporting the filing's validity
Negative
- Stake size is small at 1.4% and does not confer control or a blocking position
Insights
TL;DR: Institutional filing discloses a small passive stake; no control intent stated.
The Schedule 13G/A shows a disclosed passive holding of 1.4% of Class A shares by Gates Frontier and William H. Gates III. The filing cites Rule 13d-1(b)/(c) style reporting and includes the certification that the stake is not intended to change or influence control. At 1.4% of a 171.9 million share base, this position is immaterial from a control or blockholder standpoint but relevant for public ownership transparency and beneficial ownership records.
TL;DR: Disclosure provides clear ownership metrics but no operational or financial impact on the issuer.
The filing quantifies beneficial ownership precisely: 2,365,664 shares and 1.4% of the Class A float. It references the outstanding share count used for the percentage and includes proper signatures by an attorney-in-fact. There are no indications of additional arrangements, shared voting or dispositive power, or acquisitions tied to control, so this should not materially affect valuation or governance expectations.
FAQ
What percentage of EVLVW does the reported holding represent?
Was the stake reported as intended to influence control of Evolv Technologies?
When was the filing signed and by whom?
AI-generated analysis. How Rhea-AI works. Not financial advice.